Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Riera J
- Alcántara S
- Bonilla C
- Fortuna P
- Blandino Ortiz A
- Vaz A
- Albacete C
- Millán P
- Ricart P
- Victoria Boado M
- Ruiz de Gopegui P
- Santa Teresa P
- Sandoval E
- Pérez-Chomón H
- González-Pérez A
- Duerto J
- Colomina J
- Gómez V
- Renedo G
- Naranjo J
- Alfonso García M
- Rodríguez-Ruiz E
- Eduardo Silva P
- Pérez D
- Veganzones J
- Voces R
- Martínez S
- Blanco-Schweizer P
- García M
- Villanueva-Fernández H
- Paz Fuset M
- María Luna S
- Martínez-Martínez M
- Argudo E
- Chiscano L
- Roncon-Albuquerque R Jr
Grupos
Abstract
Series describing the evolution of patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19 and supported with extracorporeal membrane oxygenation (ECMO) during the first wave of the pandemic have reported mortalities ranging from 30 to 60% [1, 2]. More recent publications have demonstrated a trend towards a higher mortality in COVID-19 patients receiving support in later periods of the pandemic, even though the overall mortality of the disease seems lower [3, 4]. The reasons for this difference are not clear.
Datos de la publicación
- ISSN/ISSNe:
- 0903-1936, 1399-3003
- Tipo:
- Letter
- Páginas:
- -
- PubMed:
- 34824058
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 4,336 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
EUROPEAN RESPIRATORY JOURNAL EUROPEAN RESPIRATORY SOC JOURNALS LTD
Citas Recibidas en Web of Science: 28
Documentos
- No hay documentos
Filiaciones
Keywords
- MEMBRANE-OXYGENATION; DISTRESS-SYNDROME
Portal de investigación